NEW YORK, May 14 – Caliper Technologies and Pharmacopeia will be among seven new companies included in the Nasdaq Biotechnology Index as of marketing opening May 21, Nasdaq announced on Monday.
Companies included in the Index are evaluated semi-annually for minimum price, market value, and average daily share volume requirements.
Sixteen companies will be removed, including Lexicon Genetics. The Woodlands, Texas-based company on May 8 announced flat revenues first-quarter 2001 compared to the year-ago quarter.
Caliper, based in Mountain View, Calif., designs and manufactures lab-on-chip technologies. It had a market capitalization of $385 million at the time of selection.
Pharmacopeia of Princeton, NJ, has a drug discovery segment and recently merged its four software units into a single subsidiary called Accelrys. The company had a market capitalization of $23 million at the time of its selection.
The Nasdaq Biotechnology Index, which was started in 1993, increased 23 percent in 2000.